Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.
about
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.The effect of bone marrow mesenchymal stem cells on recovery of skeletal muscle after neurotization surgery in rat.Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production.Hematopoietic stem cell mobilization with plerixafor in sickle cell disease.
P2860
Bone Marrow as a Hematopoietic Stem Cell Source for Gene Therapy in Sickle Cell Disease: Evidence from Rhesus and SCD Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bone Marrow as a Hematopoietic ...... from Rhesus and SCD Patients.
@en
type
label
Bone Marrow as a Hematopoietic ...... from Rhesus and SCD Patients.
@en
prefLabel
Bone Marrow as a Hematopoietic ...... from Rhesus and SCD Patients.
@en
P2093
P2860
P356
P1476
Bone Marrow as a Hematopoietic ...... from Rhesus and SCD Patients.
@en
P2093
Allen E Krouse
Atsushi Fujita
Aylin C Bonifacino
John F Tisdale
Mark E Metzger
Matthew M Hsieh
Naoya Uchida
Robert E Donahue
P2860
P356
10.1089/HUMC.2017.029
P577
2017-04-27T00:00:00Z